Conservatives to scrap Labour’s jobs tax on NHS and use savings for cancer drugs
 
Cancer patients in Greenwich and Woolwich will get access to drugs that they are currently denied under Labour if the Conservatives win the general election, Cllr Spencer Drury, Parliamentary Candidate for Greenwich and Woolwich announced today.
 
Under the bold new plans, the NHS would save £200 million because Conservatives will stop Labour’s jobs tax on employers. This NHS saving would be used to pay for drugs which have been blocked by the Government’s quango, the National Institute for Clinical Excellence (NICE). In the South London Healthcare NHS Trust (including the Queen Elizabeth Hospital) which employs 7,111 staff, the cost of Labour’s increase in Employers’ National Insurance contributions – the jobs tax – is estimated to be £1,066,650.
 
·            The Labour Government has failed to provide patients with the cancer drugs they need – drugs which are widely available in Europe. Britain has more cancer deaths per head than Buglaria. The current system lets Ministers off the hook. They blame bad decisions on unaccountable bureaucrats in NICE, the agency which approves drugs for the NHS.
·            Under the Conservative blueprint, the money that would have been eaten up by Labour’s jobs tax would go straight to a new Cancer Drugs Fund. No cancer patient will be refused access to drugs that have been licensed since 2005 if their doctors say they need them.
·            Conservatives will also change the way that drug companies are paid for NHS medicines. Effective treatments for all conditions, not just cancer, would become available on the NHS, with drug providers paid according to the value of their new treatments.
 
Spencer said:
 
“There is a clear choice at this election: Labour and their jobs tax that will take £200 million out of the NHS budget; or the Conservatives who will stop the jobs tax and use the savings in the NHS budget to create a Cancer Drugs Fund.
 
“The NHS is our number one priority. We are committed to helping our NHS become truly world-class. Giving Greenwich and Woolwich’s patients access to cancer drugs widely available in Europe is a key part of our plan for change and making the NHS even better.”